![]() |
市场调查报告书
商品编码
1933278
全球透析市场:市场规模、市场占有率、成长率、产业分析、依类型、应用和地区划分的分析、未来预测(2026-2034)Dialysis Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
受慢性肾臟病 (CKD) 和终末期肾病 (ESRD) 患病率上升的推动,全球透析市场正经历强劲增长。根据 Fortune Business Insights 预测,全球透析市场规模预计将在 2025 年达到 1,031.5 亿美元,2026 年达到 1,096.6 亿美元。此外,预计到 2034 年将达到 2,205.1 亿美元,预测期内复合年增长率 (CAGR) 高达 9.12%。北美地区在 2025 年占市场主导地位,市占率达 40.41%。这主要得益于其先进的医疗基础设施和有利的报销政策。
市场概览
透析是肾衰竭患者维持生命的治疗方法,它能清除血液中的代谢废物和多余液体。由于糖尿病和高血压盛行率的上升以及人口老化,全球肾臟疾病负担显着加重。因此,前往肾臟治疗中心就诊的患者人数稳定成长,推动了对透析服务、耗材和设备的需求。
为了满足不断成长的需求,各大公司正积极拓展服务网络并推出创新产品。例如,西北肾臟中心于2023年3月在美国肯特开设了一家新的门诊透析中心;泰尔茂株式会社的腹膜透析液于2022年9月在中国获得监管部门批准。
透析市场趋势
透析市场最显着的趋势之一是从中心透析转向居家透析的转变。与住院治疗相比,居家透析能为患者带来更大的独立性、更高的生活品质和更低的成本效益。根据美国肾臟病学会的数据,末期肾病 (ESKD) 患者的居家透析使用率从 2016 年的 14.8% 增加到 2021 年的 20%。政府推行的旨在推广经济实惠的居家透析的举措,尤其是在美国和欧洲,预计将进一步加速这一趋势。
市场成长驱动因素
透析市场的主要成长驱动因素是慢性肾臟病 (CKD) 和末期肾病 (ESRD) 盛行率的上升。截至 2021 年,美国约有 808,536 名 ESRD 患者,其中约 71% 的患者正在接受透析治疗。据估计,2022年全球慢性肾臟病病例数将达到480万例,预计这一数字将以每年3%至6%的速度增长。
推动市场成长的另一个关键因素是血液透析中心的可近性提高,尤其是在印度和中国等新兴经济体。策略性收购和投资正在扩大全球透析基础设施。例如,2023年5月,Life Healthcare收购了费森尤斯医疗的南非肾臟诊所,从而增强了其服务能力。
限制因子
儘管市场成长强劲,但由于透析手术相关的风险和併发症,该市场仍面临挑战。血液透析可能导致心血管併发症、电解质失衡和血管通路相关感染。腹膜透析也存在腹膜炎和疝气等风险,这可能会限制其在某些患者群体中的应用。
依类型划分,透析服务将在2026年占市场主导地位,占总市场占有率的77.84%。这主要归功于肾臟护理机构数量的增加和患者数量的增长。依透析类型划分,血液透析将在2026年占市场主导地位,市占率达89.38%。这主要得益于其临床疗效和老年患者的高接受度。以最终用户划分,透析中心和医院将在2026年占83.13%的市场占有率,使得居家护理成为成长最快的细分市场。
北美仍将是领先地区,预计2025年市场规模将达416.8亿美元,其次是欧洲。亚太地区预计将实现最快成长,这主要得益于政府资金投入以及中国、印度和日本等国家肾臟护理服务覆盖范围的扩大。
The global dialysis market is witnessing robust growth driven by the rising prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD) across the world. According to Fortune Business Insights, the global dialysis market size was valued at USD 103.15 billion in 2025 and is projected to grow to USD 109.66 billion in 2026. The market is further expected to reach USD 220.51 billion by 2034, exhibiting a strong CAGR of 9.12% during the forecast period. North America dominated the market in 2025, accounting for a 40.41% market share, supported by advanced healthcare infrastructure and favorable reimbursement policies.
Market Overview
Dialysis is a life-sustaining treatment for patients suffering from kidney failure, enabling the removal of waste products and excess fluids from the blood. The growing incidence of diabetes, hypertension, and aging populations has significantly increased the burden of kidney diseases globally. As a result, patient visits to renal therapy clinics have risen steadily, boosting demand for dialysis services, consumables, and machines.
Key players are actively expanding their service networks and launching innovative products to meet rising demand. For instance, in March 2023, Northwest Kidney Centers opened a new outpatient dialysis facility in Kent, U.S., while Terumo Corporation received regulatory approval in China for its peritoneal dialysis solution in September 2022.
Dialysis Market Trends
One of the most prominent trends in the dialysis market is the shift from in-center dialysis to home dialysis. Home-based dialysis offers greater patient independence, improved quality of life, and cost-effectiveness compared to hospital-based treatments. According to the American Society of Nephrology, home dialysis adoption increased from 14.8% in 2016 to 20% in 2021 among ESKD patients. Government initiatives, especially in the U.S. and Europe, promoting affordable home care are expected to further accelerate this trend.
Market Growth Drivers
The primary growth driver of the dialysis market is the rising prevalence of CKD and ESRD. In 2021, approximately 808,536 ESRD patients were reported in the U.S., with nearly 71% undergoing dialysis. Globally, chronic kidney failure cases were estimated at 4.8 million in 2022, and this number is expected to grow annually by 3-6%.
Another key factor driving market growth is improved accessibility to hemodialysis centers, especially in emerging economies such as India and China. Strategic acquisitions and investments are expanding dialysis infrastructure worldwide. For example, in May 2023, Life Healthcare acquired Fresenius Medical Care's renal clinics in Southern Africa, strengthening service availability.
Restraining Factors
Despite strong growth, the market faces challenges due to risks and complications associated with dialysis procedures. Hemodialysis can lead to cardiovascular complications, electrolyte imbalances, and access-related infections. Peritoneal dialysis is also associated with risks such as peritonitis and hernia, which may limit adoption among certain patient groups.
By type, dialysis services dominated the market, accounting for 77.84% of the total share in 2026, owing to the increasing number of renal care facilities and patient volumes. By dialysis type, hemodialysis led the market with an 89.38% share in 2026, driven by its clinical effectiveness and higher adoption among elderly patients. By end user, dialysis centers and hospitals held 83.13% of the market share in 2026, while homecare emerged as the fastest-growing segment.
North America remained the leading region, generating USD 41.68 billion in 2025, followed by Europe. Asia Pacific is expected to witness the fastest growth due to government funding and expanding access to renal care services in countries like China, India, and Japan.
Competitive Landscape
The dialysis market is semi-consolidated, with key players such as Fresenius Medical Care, DaVita Inc., and Baxter holding a significant share. These companies are focusing on partnerships, regulatory approvals, digital health solutions, and product innovation to strengthen their market position.
Conclusion
The global dialysis market is set for substantial expansion from USD 103.15 billion in 2025 to USD 220.51 billion by 2034, driven by the rising burden of chronic kidney diseases, growing elderly population, and increasing adoption of home-based dialysis solutions. While procedural risks and complications remain key challenges, continuous technological advancements, expanding dialysis infrastructure, and supportive government initiatives are expected to outweigh these restraints. Overall, the dialysis market presents strong long-term growth opportunities for service providers, product manufacturers, and healthcare investors worldwide.
Segmentation By Type
By Dialysis Type
By End-User
By Region